(Q40616546)

22 September 2017

title

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis (English)

1 reference

22 September 2017

7

1 reference

22 September 2017

M Jensen

1

1 reference

22 September 2017

K Ernestus

2

1 reference

22 September 2017

J Kemshead

3

1 reference

22 September 2017

M Klehr

4

1 reference

22 September 2017

M S Von Bergwelt-Baildon

5

1 reference

22 September 2017

T Schinköthe

6

1 reference

22 September 2017

F Berthold

8

1 reference

22 September 2017

language of work or name

1 reference

1 November 2003

1 reference

Clinical and Experimental Immunology

22 September 2017

published in

1 reference

22 September 2017

volume

134

1 reference

22 September 2017

issue

2

1 reference

22 September 2017

page(s)

253-263

1 reference

Quantitative distribution of cluster 1 small cell lung cancer antigen in cancerous and non-cancerous tissues, cultured cells and sera

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02300.X

Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02300.X

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02300.X

Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02300.X

THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Targeted cytokine delivery to neuroblastoma

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: evidence for in situ t-cell activation and therapeutic efficacy

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

CD3 hyporesponsiveness and in vitro apoptosis are features of T cells from both malignant and nonmalignant secondary lymphoid organs

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Regression of Advanced Ovarian Carcinoma by Intraperitoneal Treatment With Autologous TLymphocytes Retargeted by a Bispecific Monoclonal Antibody

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Hybrid antibodies can target sites for attack by T cells

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Preliminary trial of specific targeting therapy against malignant glioma

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen

1 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Ocular symptoms in children treated with human-mouse chimeric anti-GD2 mAb ch14.18 for neuroblastoma

4 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1808859

Expression of the Proliferating Cell Nuclear Antigen in the Different Types of Hodgkin’s Disease

2 December 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2003.02300.X

Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody

21 January 2018

1 reference

12 December 2020

Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma

1 reference

12 December 2020

Histologic patterns of neuroblastoma related to prognosis and clinical staging

1 reference

12 December 2020

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

12 December 2020

Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 x anti-CD16) antibodies

1 reference

12 December 2020

Elimination of neuroblastoma and small-cell lung cancer cells with an anti-neural cell adhesion molecule immunotoxin

1 reference

12 December 2020

Bispecific antibodies: the new magic bullets

1 reference

12 December 2020

Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicity

1 reference

12 December 2020

Single-step purification of bispecific monoclonal antibodies for immunotherapeutic use by hydrophobic interaction chromatography

1 reference

12 December 2020

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

1 reference

12 December 2020

10.1046/J.1365-2249.2003.02300.X

Identifiers

DOI

1 reference

22 September 2017

0 references

1 reference